Real-World Results for New Alzheimer’s Drugs Show Effectiveness
Real world data from AAIC 2025 shows Alzheimer’s drugs lecanemab and donanemab match or exceed clinical trial safety, with patients reporting positive outcomes.
Real world data from AAIC 2025 shows Alzheimer’s drugs lecanemab and donanemab match or exceed clinical trial safety, with patients reporting positive outcomes.
AAIC 2025 research finds TBIs may shrink dementia-related brain areas more in women and links chemotherapy-related brain changes to memory and focus problems.
Couldn’t make it to the Alzheimer’s Society ECR Retreat? Recordings from all the sessions are now online, covering research, careers, wellbeing, and more.
The 2025 ISTAART PIA Relay Podcast playlist is now live. Six global conversations on dementia research, featuring biomarkers, nutrition, equity, and more.
Milbotix launches SmartSocks®DISCOVERY, a wearable research tool capturing real-time data for studies in dementia, Parkinson’s, sleep and movement disorders.
Recording from the DEMFEST webinar on dementia and art, sharing personal reflections, research insights, and a short exhibition created in community workshops.
New Council of Deans report urges urgent action to grow clinical academic careers in nursing, midwifery and the allied health professions.
Dr Erik Norman Dzwiza-Ohlsen & Ragna Winniewski lecture discussing their work with the Genetic Choir Ensemble in Amsterdam
The NIHR Research Delivery Network is adopting new ways of working to support research across all settings, improving access, impact, and national coordination.
New data shows 182 trials testing 138 drugs for Alzheimer’s, with diverse targets, repurposed agents, and growing use of biomarkers across all phases.
New research by UKDRI / NIA Dr Emily Simmonds & Kristin Levine reveals sleep disorders may double the risk of developing dementia and neurodegeneration later in life
New ADI report urges global action on dementia as WHO plan nears expiry. Only 45 of 194 countries have national plans. Time to deliver. Read it now.